Business Context and Reporting Period
Company: Coca-Cola Europacific Partners Plc (CCEP)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: May 18, 2026
Context: This filing is a shareholder letter providing additional context regarding specific resolutions for the Annual General Meeting (AGM) scheduled for May 28, 2026. The letter addresses divergent recommendations from proxy advisory firms (Glass Lewis, ISS, and IVIS) concerning a share buyback waiver and director re-elections.
Key Financial Metrics and Capital Allocation
- Share Buyback Programme: Announced on February 17, 2026, CCEP expects to repurchase up to €1 billion of ordinary shares across US and UK trading venues through February 2027, subject to market conditions.
- Ownership Structure: Olive currently holds approximately 37.2% of the issued share capital.
- Projected Ownership Impact: If the full buyback authority is utilized, Olive's shareholding could increase to approximately 41.4%. The Company notes this would result in substantially less than 10% of the Company's share capital being acquired.
- Liquidity and Leverage: Management states the buyback is supported by the Company's cash flows and will not introduce excessive or unsustainable leverage.
- Financial Performance: The filing text does not provide specific revenue, profit, cash flow, or margin figures for the reporting period.
Material Changes and Governance Issues
The filing highlights significant governance debates regarding three specific resolutions:
- Resolution 25 (Rule 9 Waiver): Seeks a waiver of mandatory offer provisions under Rule 9 of the Takeover Code to facilitate the share buyback. Without this waiver, Olive's shareholding increase from the buyback would trigger a mandatory general offer to all shareholders.
- Proxy Advisory Divergence:
- Glass Lewis: Recommends voting "FOR" Resolutions 7, 9, and 25.
- ISS: Recommends voting "AGAINST" Resolutions 7, 9, and 25. ISS cites outdated policy regarding Rule 9 waivers and concerns over the independence of the Remuneration Committee.
- IVIS: Assigned a "RED" designation to Resolution 25 but noted the decision is a matter for shareholder judgment.
- Remuneration Committee Composition: ISS objects to the re-election of Manolo Arroyo and José Ignacio Comenge to the Remuneration Committee, arguing they are not independent. The Board counters that the committee maintains a majority of Independent Non-executive Directors (INEDs) and that these directors have no conflicts of interest.
Management Commentary, Risks, and Outlook
- Management Stance: The Board firmly believes the resolutions are in the best interests of shareholders, enabling cash returns and long-term value delivery. They recommend voting "FOR" all resolutions.
- Olive's Intentions: Olive has confirmed it has no intention of changing its approach to CCEP or seeking changes to the general nature of the business due to any increase in shareholding. Its holding will not exceed 50% of voting rights.
- Risk Mitigation: The Company argues that ISS's concerns regarding "creeping control" are unfounded given Olive's stated intentions and existing regulatory safeguards. The Board asserts that ISS's policy on Rule 9 waivers has not been updated to reflect changes in PLSA guidelines since 2020.
- Outlook: The Company intends to proceed with the €1 billion buyback programme contingent on shareholder approval of the necessary authorities.
Key Facts for Investor Verification
- Verify the current share price to assess the actual number of shares repurchasable under the €1 billion programme and the precise dilution/accretion impact on Olive's stake.
- Confirm the exact composition of the Remuneration Committee to validate the Board's claim that a majority of members are Independent Non-executive Directors.
- Review the full Notice of Meeting dated April 16, 2026, for detailed terms of Resolutions 25, 29, and 30.
- Assess the Company's latest financial statements to independently verify that the proposed buyback is supported by cash flows and does not breach leverage covenants.
- Monitor the voting results of the AGM on May 28, 2026, specifically regarding the Rule 9 waiver, as this is a prerequisite for the buyback.